NIH-funded research R01 grant

Pharmacy-based PrEP to help women at high HIV risk stay on PrEP in Zimbabwe

Official title: A randomized trial to determine impact, cost and cost effectiveness of pharmacy-based PrEP on PrEP continuation for women at high risk of HIV

Funded at Centre/sexual Hlth/hiv Aid Res/zimbabwe · NIH-11366961 · Data updated 2026-11-12

A large randomized trial will test whether letting women get PrEP refills from local pharmacies, with support, helps them stay on PrEP and use it effectively.

More PrEP research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCentre/sexual Hlth/hiv Aid Res/zimbabwe
NIH-funded
Lab location1 site (Harare, Zimbabwe)
Project startSeptember 3, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$37,728
NIH project number3R01MH140751-01S1
Project IDNIH-11366961 on NIH RePORTER

Who could benefit from this research

Could help

Women at high risk of HIV infection in Zimbabwe who are starting PrEP and are willing to collect refills from pharmacies or KP program clinics.

Less likely to help

Participants who prefer clinic-only services or have barriers to pharmacy access may not experience additional benefit.

What this research studies

This study tests a practical approach to PrEP access for women at high risk of HIV in Zimbabwe by enabling pharmacy-based refill pickup alongside short-term incentives. It builds on a successful pilot (TOPAZ) and compares the pharmacy-based option to standard clinic-based PrEP services to see which keeps people on PrEP longer and more consistently. Participants will be adults who start PrEP and choose to obtain refills at community pharmacies or KP program clinics, with close follow-up and data collection on continuation, costs, and outcomes. The trial aims to inform scalable strategies to reduce new HIV infections among women in high-burden settings.

Why it matters

Potential benefit: If successful, the approach could make PrEP easier to access and maintain, potentially reducing HIV infections among women at high risk.

How similar studies have gone: Pilot TOPAZ showed high acceptability and promising effectiveness signals, justifying a larger trial.

Where this research is happening

  • Centre/sexual Hlth/hiv Aid Res/zimbabwe
    Harare, Zimbabwe
    Active

Researchers

  • Principal investigator: Sibanda, Euphemia Lindelwe — Centre/sexual Hlth/hiv Aid Res/zimbabwe
  • Study coordinator: Sibanda, Euphemia Lindelwe

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.